Testosterone Suppression in Patients with Intermediate Risk Prostate Cancer Treated with External Beam Radiotherapy Alone

被引：0
|
作者：
Nabid, A. [1 ]
Carrier, N. [1 ]
Vigneault, E. [2 ]
Souhami, L. [3 ]
Lemaire, C. [4 ]
Brassard, M. [5 ]
Bahoric, B. [6 ]
Archambault, R. [7 ]
Vincent, F. [8 ]
Nguyen, T. [9 ]
机构：
[1] CHUS Hop Fleurimont, Sherbrooke, PQ, Canada
[2] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada
[3] Ctr Univ Sante McGill, Montreal, PQ, Canada
[4] Hop Maison Neuve Rosemont, Montreal, PQ, Canada
[5] Ctr Sante & Serv Sociaux Chicoutimi, Chicoutimi, PQ, Canada
[6] Hop Gen Juif, Montreal, PQ, Canada
[7] Hop Gatineau, Gatineau, PQ, Canada
[8] Ctr Hosp Reg Trois Rivieres, Trois Rivieres, PQ, Canada
[9] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 81卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2011.06.085
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] TREATING INTERMEDIATE RISK PROSTATE CANCER WITH HYPOFRACTIONATED EXTERNAL BEAM RADIOTHERAPY ALONE
    Dal Pra, A.
    Faria, S.
    Cury, F.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S418 - S418
  • [2] Outcomes of Patients With Unfavorable Intermediate-Risk Prostate Cancer Treated With External-Beam Radiotherapy Versus Brachytherapy Alone
    Andruska, Neal
    Fischer-Valuck, Benjamin W.
    Carmona, Ruben
    Agabalogun, Temitope
    Brenneman, Randall J.
    Gay, Hiram A.
    Michalski, Jeff M.
    Baumann, Brian C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (04): : 343 - +
  • [3] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Faria, Sergio
    Dal Pra, Alan
    Cury, Fabio
    David, Marc
    Duclos, Marie
    Freeman, Carolyn R.
    Souhami, Luis
    RADIOTHERAPY AND ONCOLOGY, 2011, 101 (03) : 486 - 489
  • [4] Treating intermediate-risk prostate cancer with hypofractionated external beam radiotherapy alone
    Dal Pra, A.
    Faria, S.
    Cury, F. L.
    David, M.
    Duclos, M.
    Shenouda, G.
    Souhami, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [5] Moderate hypofractionated external beam radiotherapy alone for intermediate risk prostate cancer: long term outcomes
    Faria, Sergio L.
    Neto, Osmar B.
    Cury, Fabio
    Shenouda, George
    Russel, Ruo
    Souhami, Luis
    CANADIAN JOURNAL OF UROLOGY, 2016, 23 (02) : 8209 - 8214
  • [6] The dose response characteristics of low and intermediate risk prostate cancer treated with external beam radiotherapy
    Cheung, R
    Tucker, S
    Lee, A
    de Crevoisier, R
    Dong, L
    Kamat, A
    Pisters, L
    Kuban, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S451 - S452
  • [7] COMPARISON OF CLINICAL OUTCOME IN INTERMEDIATE RISK PROSTATE CANCER PATIENT TREATED WITH PERMANENT SEEDS IMPLANT ALONE OR EXTERNAL BEAM RADIOTHERAPY WITH HDR BOOST
    Vigneault, E.
    Martin, A. -G.
    Laflamme, N.
    Beaulieu, L.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S2 - S2
  • [8] Quality of life in intermediate or high risk prostate cancer patients treated by external beam radiotherapy and brachytherapy with or without androgen deprivation
    Lacorte-Pi, T. M.
    Guix-Melcior, B.
    Guedea-Edo, F.
    PSYCHO-ONCOLOGY, 2006, 15 (02) : S296 - S297
  • [9] External Beam Radiotherapy Affects Serum Testosterone in Patients With Localized Prostate Cancer
    Pompe, Raisa S.
    Karakiewicz, Pierre I.
    Zaffuto, Emanuele
    Smith, Ariane
    Bandini, Marco
    Marchioni, Michele
    Tian, Zhe
    Leyh-Bannurah, Sami-Ramzi
    Schiffmann, Jonas
    Delouya, Guila
    Lambert, Carole
    Bahary, Jean-Paul
    Beauchemin, Marie Claude
    Barkati, Maroie
    Menard, Cynthia
    Graefen, Markus
    Saad, Fred
    Tilki, Derya
    Taussky, Daniel
    JOURNAL OF SEXUAL MEDICINE, 2017, 14 (07): : 876 - 882
  • [10] Intermediate-risk prostate cancer treated with external beam radiotherapy (EBRT): A risk group with heterogeneous behavior.
    Perez de la Puente, Constanza
    Losco, Federico
    Chacon, Carolina
    Pablo Sade, Juan
    Giornelli, Gonzalo H.
    Chacon, Matias
    Chacon, Reinaldo D.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345